Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

62%

8 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
8(66.7%)
Phase 1
3(25.0%)
N/A
1(8.3%)
12Total
Phase 4(8)
Phase 1(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT03533972Phase 1Completed

Effect of Ashwagandha on Salivary Antioxidant and Serum c Reactive Protein in Chronic Generalized Periodontitis

Role: lead

NCT03520595Not ApplicableCompleted

Analgesic Efficacy of Arnica Montana in Comparison With Diclofenac Sodium Following a Periodontal Surgical Procedure

Role: lead

NCT03519152Phase 1Completed

To Compare Efficacy of Low Dose Diclofenac (25mg) in Management of Postoperative Pain After Periodontal Flap Surgery

Role: lead

NCT03516370Phase 1Completed

Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis

Role: lead

NCT02886676Phase 4Completed

Effect of Arthrospira Platensis (Spirulina) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant Levels in Chronic Periodontitis Subjects

Role: lead

NCT02583841Phase 4Completed

"Effect of Scaling and Root Planing on Liver Function Test (Alanine Aminotransferase and Aspartate Aminotransferase) in Systemically Healthy - Chronic Periodontitis Subjects: a Clinical Trial."

Role: lead

NCT02442453Phase 4Completed

Effect of Scaling and Root Planing Along With Topical Application of Commercially Available Curcuma Longa Gel on Superoxide Dismutase and Malondialdehyde Levels in Saliva of Chronic Periodontitis Patients

Role: lead

NCT02154594Phase 4Completed

"The Efficacy of Acacia Catechu Mouthrinse as Antiplaque and Antigingivitis Agent in Fixed Orthodontic Appliance Patients.

Role: lead

NCT02149758Phase 4Completed

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

Role: lead

NCT02014532Phase 4Completed

Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis

Role: lead

NCT01997814Phase 4Completed

Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis

Role: lead

NCT01997853Phase 4Completed

Omega-3 Fatty Acids in Chronic Periodontitis.

Role: lead

NCT01900535Completed

Evaluation and Comparison of the Efficacy of Triphala Mouthwash and 0.2% Chlorhexidine

Role: lead

All 13 trials loaded